FDA's 510(k) process changes: group in Congress is pushing back

A group of 12 lawmakers from the House of Representatives asked the FDA to delay implementation of five proposed changes to the 510(k) process until the FDA provides more details. They did so in a letter to Dr. Hamburg. See the FDA Law blog for more details.